07630.HK 股價走勢圖
IMPACT THERAP-B (07630.HK)
南京英派藥業股份有限公司
HK$40.08
0.09%
$0.03
休市： Jun 04, 16:00:00 HKT
返回
南京英派藥業股份有限公司 (07630.HK)
關鍵數據
前收市價
$40.04
開盤價
$40.04
當日範圍
$38.48 - $40.38
52週區間
$28.2 - $47.98
交易量
865.0K
平均成交量
1.7M
股息收益率
--
每股盈餘 (TTM)
-1.24
市值
$11.0B
什麼是 IMPACT THERAP-B？
IMPACT Therapeutics Inc is a CN-based company operating in industry. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2026-05-13. IMPACT Therapeutics Inc is a China-based company mainly engaged in biotechnology research and commercialization. The firm is in the commercialization stage. The firm is committed to advancing synthetic lethality (SL)-based precision anti-cancer therapies globally. The firm's independently developed core product, senaparib, in China as a 1L maintenance therapy for ovarian cancer (OC). The firm is currently developing product pipeline packages such as PARP1/2, PARP1, ATR, WEE1, PKMYT1/WEE1, DHX9, ATM, USP1, and CHK1/2.
